MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Shekhat Denil Nanji
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez
MIRA Pharmaceuticals | 10-Q: Quarterly report
MIRA Pharmaceuticals | 10-K: Annual report
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Shekhat Denil Nanji
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Yanez Michelle
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jerman Michael Allen
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MacPherson Edward Clouston
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Del Giudice Matthew Paul
MIRA Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Shekhat Denil Nanji
MIRA Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Del Giudice Matthew Paul
MIRA Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director MacPherson Edward Clouston
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 8-K: Current report
No Data